Related Experiment Video
Updated: Jul 18, 2026
08:23
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Generalized additive model demonstrates fluoroquinolone use/resistance relationships for Staphylococcus aureus
Pierre Berger1, Laurence Pascal, Catherine Sartor
1Laboratoire d'Evaluation Hospitalière-Mesure de la Santé Perçue, Faculté de Médecine, Marseilles, France.
European Journal of Epidemiology
|July 6, 2004
Summary
This study reveals a significant temporal link between fluoroquinolone use and the rise of fluoroquinolone-resistant Staphylococcus aureus. Advanced statistical modeling identified this crucial relationship in hospital settings.
Area of Science:
- Medical Microbiology
- Biostatistics
- Infectious Diseases
Background:
- Current mathematical models inadequately address the complex relationship between antibiotic usage and resistance.
- Existing models often fail to integrate temporal and spatial analyses simultaneously, limiting understanding of resistance dynamics.
- The precise form of the relationship between antibiotic prevalence and resistance remains largely unknown.
Purpose of the Study:
- To investigate the temporal relationship between fluoroquinolone use and the incidence of fluoroquinolone-resistant Staphylococcus aureus.
- To apply the Generalized Additive Model (GAM) for simultaneous temporal and area-based analyses of antibiotic resistance.
- To analyze resistance patterns within an institutional setting over a three-year period.
Main Methods:
- Utilized the Generalized Additive Model (GAM) for a robust statistical analysis.
- Conducted analyses at both the overall institutional level and within individual hospital units.
- Examined fluoroquinolone use and the incidence of fluoroquinolone-resistant Staphylococcus aureus over a 3-year timeframe.
Main Results:
- A significant temporal relationship was identified between fluoroquinolone use and the incidence of fluoroquinolone-resistant Staphylococcus aureus.
- An increased relative risk (RR) of 1.27 (95% CI: 1.13-1.42) was observed for rising fluoroquinolone use.
- In surgery units, a RR of 1.23 (95% CI: 1.01-1.50) was noted for fluoroquinolone use with a 2-month lag.
Conclusions:
- The Generalized Additive Model (GAM) successfully demonstrated a significant temporal association between fluoroquinolone consumption and nosocomial S. aureus resistance.
- Findings highlight the importance of integrated temporal and spatial analyses in understanding antibiotic resistance.
- The study provides crucial insights for developing targeted interventions to combat antibiotic resistance in healthcare settings.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
07:44Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
Related Concept Videos
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...